Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

16.25
-0.0900-0.55%
Post-market: 16.700.4500+2.77%19:52 EST
Volume:233.25K
Turnover:3.80M
Market Cap:207.81M
PE:-1.00
High:16.59
Open:16.15
Low:15.85
Close:16.34
52wk High:69.97
52wk Low:6.76
Shares:12.79M
Float Shares:11.47M
Volume Ratio:0.64
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.2249
EPS(LYR):-176.5980
ROE:-64.99%
ROA:-35.94%
PB:0.90
PE(LYR):-0.09

Loading ...

Alliance Global Partners Sticks to Its Buy Rating for Tonix Pharma (TNXP)

TIPRANKS
·
Yesterday

Tonix Pharmaceuticals steigert die Investitionen im Gesamtjahr 2025 auf 3,4 Mio. USD, ein Anstieg um das 34-Fache

Reuters
·
Feb 03

BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology

Reuters
·
Jan 30

BUZZ-Tonix pain‑relief drug meets main goal in late‑stage study; shares fall

Reuters
·
Jan 30

Tonix Pharmaceuticals - Tonmya Reduces Pain Scores Significantly at Week 14

THOMSON REUTERS
·
Jan 30

Tonix Pharmaceuticals: Treatment Was Well Tolerated With Minimal Effects on Weight or Blood Pressure

THOMSON REUTERS
·
Jan 30

Tonix Pharmaceuticals: Tonmya Demonstrated Significant Reduction in Fibromyalgia Pain Compared With Placebo in Phase 3 Resilient Study

THOMSON REUTERS
·
Jan 30

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

GlobeNewswire
·
Jan 30

Tonix Pharmaceuticals Showcases Pipeline Progress and Fibromyalgia Drug Launch in Investor Presentation

Reuters
·
Jan 22

Tonix Pharmaceuticals Unveils Investor Presentation Highlighting FDA Approvals and Pipeline Advances

Reuters
·
Jan 10

Tonix Pharmaceuticals CEO to Present at Neuroscience Innovation Forum and Biotech Showcase

Reuters
·
Jan 06

Point72 Asset Management Lp Reports 9.2% Passive Stake in Tonix Pharmaceuticals as of Dec 29 - SEC Filing

THOMSON REUTERS
·
Jan 01

Corrected-Tonix Pharmaceuticals Shares up 5.9% After Announcing $20 Mln Direct Stock Deal (Corrects to Remove Reference to Premarket)

THOMSON REUTERS
·
Dec 29, 2025

Tonix Pharmaceuticals Shares up 5.9% Premarket After Announcing $20 Mln Direct Stock Deal

THOMSON REUTERS
·
Dec 29, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Vail Resorts, Tonix, Praxis Precision, AXT

Reuters
·
Dec 29, 2025

Tonix Pharmaceuticals Shares Fall 6.4% Premarket After Co Prices Stock and Warrant Offering

THOMSON REUTERS
·
Dec 29, 2025

Tonix Pharmaceuticals - Announces Securities Purchase Agreement With Point72

THOMSON REUTERS
·
Dec 29, 2025

Press Release: Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering

Dow Jones
·
Dec 29, 2025

Tonix Pharmaceuticals Unveils Phase 2/3-Ready Monoclonal Antibody for Lyme Disease Prevention

Reuters
·
Dec 29, 2025

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (Mab) Designed for Seasonal Prevention of Lyme Disease (Tnx-4800)

THOMSON REUTERS
·
Dec 29, 2025